MALVERN, Pa.--(BUSINESS WIRE)--Vector Biolabs, a custom design and manufacturing service provider for AAV and adenovirus viral vectors announced the completion of a facility expansion to meet growing ...

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf Rep/Cap plasmid offering, designed to streamline ...

Kite Pharma's viral vector plant in Southern California has been cleared for liftoff, and, with that, the Gilead Sciences company is touting its position as the only cell therapy player able to make ...

Viral vectors are a key component of many advanced gene therapies and vaccines, but reliable, large-scale manufacturing remains a significant challenge. Continued innovation in vector design, cell ...

Viral vector-based gene therapies hold immense promise for treating a multitude of diseases. However, their widespread adoption has been hindered by inefficient manufacturing methods and the absence ...

- New, $110 million facility will more than double existing production capacity - Supports large-scale commercial manufacturing of viral and gene therapy products BURLINGTON, Mass., April 21, 2020 ...

In its study database, Polaris Market Research, a research consulting firm, issued a [110+] page research report on “Viral Vector Manufacturing Market: By Size, Share, Growth, Segments, Analysis and ...

(MENAFN- EIN Presswire) EINPresswire/ -- What Is The Viral Vector Manufacturing Market Size And Growth? In recent years, the viral vector manufacturing market has seen a swift expansion. The market is ...

The global viral vector manufacturing market is projected to expand at a robust CAGR of approximately 20% over the forecast period, supported by multiple transformative forces reshaping the ...

Austin, Texas, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Viral Vectors and Plasmid DNA Manufacturing Market Size & Growth Analysis: According to SNS Insider, the Viral Vectors and Plasmid DNA Manufacturing ...

Vector Biolabs, a custom design and manufacturing service provider for AAV and adenovirus viral vectors announced the completion of a facility expansion to meet growing demand. The purpose of the ...